Global Health Limited (MEDANTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Global Health Limited (MEDANTA) has a cash flow conversion efficiency ratio of 0.089x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.29 Billion ≈ $35.53 Million USD) by net assets (Rs37.10 Billion ≈ $401.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEDANTA market cap for the company's overall valuation and market capitalisation.
Global Health Limited - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Global Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Global Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Global Health Limited ranked by their cash flow conversion efficiency. Explore Global Health Limited (MEDANTA) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Primoris Services Corporation
NYSE:PRIM
|
0.112x |
|
Turk Telekomunikasyon AS
IS:TTKOM
|
0.158x |
|
CECO Environmental Corp.
NASDAQ:CECO
|
-0.009x |
|
Cenergy Holdings SA
BR:CENER
|
-0.040x |
|
Shapir Engineering Industry
TA:SPEN
|
-0.053x |
|
TSINGTAO BREWE. H ADR/5
F:TSI0
|
N/A |
|
Shanghai Sinyang Semiconductor
SHE:300236
|
0.042x |
|
Jinneng Holding Shanxi Coal Industry Co Ltd
SHG:601001
|
0.030x |
Annual Cash Flow Conversion Efficiency for Global Health Limited (2019–2026)
The table below shows the annual cash flow conversion efficiency of Global Health Limited from 2019 to 2026. View MEDANTA stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs39.84 Billion ≈ $430.88 Million |
Rs7.53 Billion ≈ $81.45 Million |
0.189x | +2.66% |
| 2025-03-31 | Rs33.88 Billion ≈ $366.35 Million |
Rs6.24 Billion ≈ $67.46 Million |
0.184x | -12.59% |
| 2024-03-31 | Rs29.06 Billion ≈ $314.23 Million |
Rs6.12 Billion ≈ $66.19 Million |
0.211x | -20.64% |
| 2023-03-31 | Rs24.28 Billion ≈ $262.60 Million |
Rs6.45 Billion ≈ $69.70 Million |
0.265x | +37.81% |
| 2022-03-31 | Rs16.16 Billion ≈ $174.77 Million |
Rs3.11 Billion ≈ $33.66 Million |
0.193x | +10.13% |
| 2021-03-31 | Rs13.82 Billion ≈ $149.50 Million |
Rs2.42 Billion ≈ $26.15 Million |
0.175x | +34.82% |
| 2020-03-31 | Rs13.50 Billion ≈ $145.95 Million |
Rs1.75 Billion ≈ $18.93 Million |
0.130x | +11.84% |
| 2019-03-31 | Rs13.31 Billion ≈ $143.93 Million |
Rs1.54 Billion ≈ $16.69 Million |
0.116x | -- |
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emerg… Read more